[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
:: Volume 12, Issue 2 (12-2018) ::
Iran J Virol 2018, 12(2): 38-40 Back to browse issues page
The MiR-29 Family as Novel Therapeutic Option for Retroviral Infection
Masoud Keikha, Mohsen Karbalaei *
Department of Microbiology and Virology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.
Abstract:   (2113 Views)
This article has no abstract.
Full-Text [PDF 364 kb]   (1191 Downloads)    
Type of Study: Letter to editor | Subject: General
Received: 2019/04/18 | Accepted: 2019/11/27 | Published: 2019/11/27
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Keikha M, Karbalaei M. The MiR-29 Family as Novel Therapeutic Option for Retroviral Infection. Iran J Virol. 2018; 12 (2) :38-40
URL: http://journal.isv.org.ir/article-1-350-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 2 (12-2018) Back to browse issues page
Persian site map - English site map - Created in 0.05 seconds with 29 queries by YEKTAWEB 4463